Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 58 | 2024 | 3204 | 7.340 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 18 | 2024 | 556 | 3.330 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 7 | 2024 | 254 | 2.870 |
Why?
|
| Magnetic Resonance Imaging | 78 | 2024 | 36290 | 2.130 |
Why?
|
| Cerebral Cortex | 18 | 2024 | 5761 | 1.940 |
Why?
|
| Receptors, GABA | 4 | 2024 | 305 | 1.360 |
Why?
|
| Meninges | 2 | 2024 | 197 | 0.990 |
Why?
|
| Brain | 38 | 2024 | 26951 | 0.950 |
Why?
|
| Spinal Cord | 8 | 2024 | 1817 | 0.930 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2020 | 3340 | 0.900 |
Why?
|
| Positron-Emission Tomography | 12 | 2024 | 6465 | 0.810 |
Why?
|
| Brain Mapping | 18 | 2019 | 6568 | 0.760 |
Why?
|
| Trigeminal Nerve | 2 | 2014 | 248 | 0.670 |
Why?
|
| Myelin Sheath | 5 | 2024 | 652 | 0.670 |
Why?
|
| Nerve Degeneration | 2 | 2017 | 748 | 0.660 |
Why?
|
| Migraine with Aura | 3 | 2020 | 203 | 0.660 |
Why?
|
| Hemostatics | 1 | 2021 | 243 | 0.630 |
Why?
|
| Interferon-beta | 5 | 2015 | 345 | 0.610 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2015 | 952 | 0.590 |
Why?
|
| Thalamus | 4 | 2020 | 1041 | 0.590 |
Why?
|
| Pyrimidines | 3 | 2019 | 3016 | 0.530 |
Why?
|
| Periaqueductal Gray | 2 | 2016 | 110 | 0.500 |
Why?
|
| Atrophy | 10 | 2024 | 1627 | 0.480 |
Why?
|
| Disease Progression | 17 | 2024 | 13502 | 0.480 |
Why?
|
| Somatosensory Cortex | 4 | 2013 | 511 | 0.480 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2019 | 2782 | 0.470 |
Why?
|
| Microglia | 2 | 2023 | 1351 | 0.460 |
Why?
|
| Meningitis | 1 | 2015 | 218 | 0.440 |
Why?
|
| Neural Pathways | 4 | 2016 | 3040 | 0.420 |
Why?
|
| Migraine without Aura | 1 | 2013 | 82 | 0.410 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 2012 | 32 | 0.410 |
Why?
|
| Leukoencephalopathies | 3 | 2022 | 249 | 0.400 |
Why?
|
| Cortical Spreading Depression | 2 | 2020 | 288 | 0.390 |
Why?
|
| Cerebellum | 1 | 2019 | 1496 | 0.390 |
Why?
|
| Inflammation | 4 | 2020 | 10756 | 0.390 |
Why?
|
| Gadolinium | 4 | 2015 | 959 | 0.370 |
Why?
|
| Adult | 59 | 2024 | 219994 | 0.360 |
Why?
|
| Migraine Disorders | 2 | 2014 | 1693 | 0.350 |
Why?
|
| Humans | 93 | 2024 | 760621 | 0.330 |
Why?
|
| Disability Evaluation | 9 | 2024 | 1826 | 0.320 |
Why?
|
| Axons | 7 | 2024 | 1673 | 0.310 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 351 | 0.300 |
Why?
|
| Executive Function | 1 | 2016 | 1374 | 0.300 |
Why?
|
| Motor Cortex | 5 | 2009 | 995 | 0.300 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 1174 | 0.290 |
Why?
|
| Hyperesthesia | 1 | 2007 | 23 | 0.280 |
Why?
|
| Male | 59 | 2024 | 359744 | 0.270 |
Why?
|
| Oxygen | 4 | 2015 | 4193 | 0.260 |
Why?
|
| Female | 59 | 2024 | 391270 | 0.260 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2007 | 246 | 0.250 |
Why?
|
| Memory | 2 | 2006 | 2179 | 0.250 |
Why?
|
| Amygdala | 1 | 2013 | 1351 | 0.250 |
Why?
|
| Middle Aged | 37 | 2024 | 220352 | 0.240 |
Why?
|
| Attention | 2 | 2006 | 2387 | 0.240 |
Why?
|
| Cerebral Veins | 2 | 2016 | 157 | 0.230 |
Why?
|
| Energy Metabolism | 2 | 2014 | 2869 | 0.230 |
Why?
|
| 4-Aminopyridine | 1 | 2004 | 80 | 0.230 |
Why?
|
| Cognition Disorders | 3 | 2015 | 3976 | 0.230 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 1171 | 0.220 |
Why?
|
| Potassium Channel Blockers | 1 | 2004 | 161 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 12 | 2020 | 8950 | 0.220 |
Why?
|
| Acetamides | 1 | 2024 | 256 | 0.210 |
Why?
|
| Brain Stem | 1 | 2007 | 857 | 0.190 |
Why?
|
| Neuronal Plasticity | 4 | 2006 | 1430 | 0.190 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 542 | 0.190 |
Why?
|
| Consensus | 2 | 2024 | 3113 | 0.190 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 20080 | 0.180 |
Why?
|
| Prospective Studies | 9 | 2022 | 54303 | 0.180 |
Why?
|
| Neuropsychological Tests | 6 | 2018 | 7021 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2015 | 4642 | 0.170 |
Why?
|
| Motor Activity | 4 | 2005 | 2687 | 0.160 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 791 | 0.140 |
Why?
|
| Gadolinium DTPA | 2 | 2004 | 823 | 0.140 |
Why?
|
| Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
| Myotonic Dystrophy | 2 | 2009 | 78 | 0.140 |
Why?
|
| Fatigue | 2 | 2004 | 1544 | 0.130 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 828 | 0.130 |
Why?
|
| Evoked Potentials, Motor | 3 | 2009 | 461 | 0.130 |
Why?
|
| Encephalitis | 1 | 2019 | 437 | 0.120 |
Why?
|
| Case-Control Studies | 5 | 2018 | 22053 | 0.120 |
Why?
|
| Algorithms | 2 | 2014 | 13981 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14660 | 0.120 |
Why?
|
| Anisotropy | 1 | 2017 | 1278 | 0.110 |
Why?
|
| Electromagnetic Phenomena | 1 | 2015 | 161 | 0.110 |
Why?
|
| Afferent Pathways | 1 | 2014 | 299 | 0.110 |
Why?
|
| Functional Laterality | 4 | 2015 | 2253 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 1999 | 1019 | 0.100 |
Why?
|
| Pyridines | 1 | 2024 | 2879 | 0.100 |
Why?
|
| Neuroglia | 1 | 2017 | 944 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 3 | 2002 | 1039 | 0.100 |
Why?
|
| Fibromyalgia | 1 | 2016 | 401 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 2884 | 0.090 |
Why?
|
| Corpus Callosum | 3 | 2022 | 749 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2015 | 4048 | 0.090 |
Why?
|
| Movement Disorders | 1 | 2015 | 459 | 0.090 |
Why?
|
| Nociceptors | 1 | 2014 | 457 | 0.090 |
Why?
|
| Prognosis | 4 | 2023 | 29658 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2017 | 974 | 0.080 |
Why?
|
| Physical Stimulation | 2 | 2007 | 518 | 0.080 |
Why?
|
| Touch | 2 | 2007 | 312 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 878 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 1463 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 15840 | 0.070 |
Why?
|
| Aged | 9 | 2024 | 169152 | 0.070 |
Why?
|
| Trigeminal Nuclei | 1 | 2006 | 39 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2018 | 41335 | 0.070 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2009 | 367 | 0.070 |
Why?
|
| Nerve Net | 1 | 2018 | 2261 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 14495 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 25942 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 39261 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2007 | 498 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2014 | 2881 | 0.060 |
Why?
|
| Psychomotor Performance | 3 | 2007 | 1878 | 0.060 |
Why?
|
| Age Distribution | 1 | 2009 | 2893 | 0.050 |
Why?
|
| Risk | 1 | 2015 | 9631 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2007 | 603 | 0.050 |
Why?
|
| Cognition | 2 | 2014 | 6957 | 0.050 |
Why?
|
| Movement | 1 | 2009 | 1474 | 0.050 |
Why?
|
| Young Adult | 6 | 2021 | 58741 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18416 | 0.050 |
Why?
|
| Diffusion | 1 | 2024 | 813 | 0.050 |
Why?
|
| Reaction Time | 2 | 2007 | 2075 | 0.050 |
Why?
|
| Models, Neurological | 3 | 2009 | 1758 | 0.050 |
Why?
|
| Magnetics | 1 | 2004 | 600 | 0.050 |
Why?
|
| Pyramidal Tracts | 1 | 2002 | 250 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 2013 | 959 | 0.050 |
Why?
|
| Disabled Persons | 3 | 2005 | 1223 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15289 | 0.040 |
Why?
|
| Fibrin | 1 | 2022 | 505 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.040 |
Why?
|
| Hemostasis | 1 | 2022 | 468 | 0.040 |
Why?
|
| Electromyography | 1 | 2004 | 1388 | 0.040 |
Why?
|
| Creatine | 1 | 2001 | 426 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2001 | 576 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2000 | 344 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2020 | 373 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2061 | 0.040 |
Why?
|
| Mental Recall | 1 | 2004 | 1206 | 0.040 |
Why?
|
| Home Care Services | 1 | 2004 | 654 | 0.040 |
Why?
|
| Estradiol | 1 | 2005 | 1932 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2019 | 2385 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 978 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2017 | 557 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 293 | 0.030 |
Why?
|
| Observer Variation | 2 | 2018 | 2601 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 1999 | 536 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2015 | 65017 | 0.030 |
Why?
|
| Apomorphine | 1 | 1995 | 149 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 815 | 0.030 |
Why?
|
| Contrast Media | 4 | 2004 | 5305 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 9962 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1334 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2002 | 2913 | 0.030 |
Why?
|
| Testosterone | 1 | 2005 | 2470 | 0.030 |
Why?
|
| Antibodies | 1 | 2002 | 2421 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6414 | 0.030 |
Why?
|
| Narcotics | 1 | 1995 | 336 | 0.030 |
Why?
|
| Dopamine Agonists | 1 | 1995 | 352 | 0.030 |
Why?
|
| Heart | 1 | 2006 | 4393 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2254 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 1869 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2002 | 1588 | 0.030 |
Why?
|
| Estrogens | 1 | 1999 | 1520 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 994 | 0.030 |
Why?
|
| Caregivers | 1 | 2004 | 2224 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1796 | 0.020 |
Why?
|
| Adolescent | 8 | 2020 | 87810 | 0.020 |
Why?
|
| Paresis | 2 | 2002 | 177 | 0.020 |
Why?
|
| Health Status | 1 | 2004 | 4081 | 0.020 |
Why?
|
| Polysomnography | 1 | 2017 | 1825 | 0.020 |
Why?
|
| Cocaine | 1 | 1995 | 961 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12427 | 0.020 |
Why?
|
| Rats | 2 | 2024 | 23711 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6238 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 3765 | 0.020 |
Why?
|
| Neurophysiology | 1 | 2009 | 144 | 0.020 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2009 | 1469 | 0.020 |
Why?
|
| Paresthesia | 1 | 2009 | 162 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2557 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 80372 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6544 | 0.020 |
Why?
|
| Recurrence | 1 | 1999 | 8482 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2007 | 6360 | 0.020 |
Why?
|
| Reference Values | 2 | 2004 | 4925 | 0.020 |
Why?
|
| Pons | 1 | 2006 | 239 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12965 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2004 | 143 | 0.010 |
Why?
|
| Depression | 1 | 2004 | 8044 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8555 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 2004 | 257 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 1274 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 347 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 22023 | 0.010 |
Why?
|
| Motor Skills | 1 | 2006 | 520 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1735 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 863 | 0.010 |
Why?
|
| Animals | 3 | 2024 | 167963 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12159 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 916 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 622 | 0.010 |
Why?
|
| Optic Neuritis | 1 | 2002 | 174 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2002 | 412 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2002 | 369 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 4174 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 1764 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2002 | 850 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 1428 | 0.010 |
Why?
|
| Hand | 1 | 2002 | 903 | 0.010 |
Why?
|
| Steroids | 1 | 2002 | 928 | 0.010 |
Why?
|
| Affect | 1 | 2004 | 1480 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1296 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 1548 | 0.010 |
Why?
|
| Time Factors | 3 | 2002 | 40165 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1995 | 333 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81208 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4899 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2004 | 2511 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7269 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6498 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10547 | 0.010 |
Why?
|
| Software | 1 | 2004 | 4419 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 9426 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58995 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8158 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1995 | 6381 | 0.000 |
Why?
|
Concepts
(227)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_